|
US5962030A
(en)
|
1997-03-07 |
1999-10-05 |
Akesis Pharmaceuticals, Inc. |
Dietary supplement and method of treatment for diabetic control
|
|
GB9715444D0
(en)
*
|
1997-07-22 |
1997-09-24 |
Scotia Holdings Plc |
Therapeutic and dietary compositions
|
|
IT1302125B1
(it)
*
|
1998-08-03 |
2000-07-31 |
Sigma Tau Healthscience Spa |
Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
|
|
IT1302307B1
(it)
|
1998-09-01 |
2000-09-05 |
Sigma Tau Healthscience Spa |
Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
|
|
US6376549B1
(en)
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
|
CA2344246A1
(en)
|
1998-09-17 |
2000-03-23 |
Akesis Pharmaceuticals, Inc. |
Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
|
|
IT1302365B1
(it)
*
|
1998-10-09 |
2000-09-05 |
Sigma Tau Healthscience Spa |
Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
|
|
IT1306130B1
(it)
*
|
1999-04-16 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
|
|
IT1306133B1
(it)
*
|
1999-04-22 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
|
|
IT1306179B1
(it)
*
|
1999-07-28 |
2001-05-30 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
|
|
DK1218001T3
(da)
*
|
1999-09-03 |
2009-04-14 |
Sigma Tau Healthscience Spa |
Ultrafint L-carnitin, fremgangsmåder til fremstilling deraf, sammensætninger indeholdende det og fremgangsmåder til anvendelse deraf
|
|
IT1316998B1
(it)
*
|
2000-03-02 |
2003-05-26 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
|
|
IT1316997B1
(it)
*
|
2000-03-02 |
2003-05-26 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
|
|
WO2002009693A1
(en)
*
|
2000-08-02 |
2002-02-07 |
Pharmanutrients |
Method and compositions for prevention and/or treatment of diabetes and glucose modulation
|
|
US8669282B2
(en)
|
2000-10-31 |
2014-03-11 |
Hill's Pet Nutrition, Inc. |
Companion animal compositions including lipoic acid and methods of use thereof
|
|
US20020076470A1
(en)
|
2000-10-31 |
2002-06-20 |
Colgate-Palmolive Company |
Composition and method
|
|
US20020098247A1
(en)
*
|
2000-11-02 |
2002-07-25 |
Komorowski James R. |
Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
|
|
WO2002043507A2
(en)
*
|
2000-11-30 |
2002-06-06 |
The Health Research Institute |
Nutrient supplements and methods for treating autism and for preventing the onset of autism
|
|
US6555573B2
(en)
|
2000-12-21 |
2003-04-29 |
The Quigley Corporation |
Method and composition for the topical treatment of diabetic neuropathy
|
|
US20060062864A1
(en)
*
|
2000-12-28 |
2006-03-23 |
Mccleary Edward L |
Weight loss composition and method
|
|
US20040043013A1
(en)
|
2000-12-28 |
2004-03-04 |
Mccleary Edward Larry |
Metabolic uncoupling therapy
|
|
ITBS20010027A1
(it)
*
|
2001-03-23 |
2002-09-23 |
Gen Topics Srl |
Principio attivo a base di acido lipoico ed acidi grassi polienolici
|
|
US6964969B2
(en)
|
2001-04-19 |
2005-11-15 |
Mccleary Edward Larry |
Composition and method for treating impaired or deteriorating neurological function
|
|
US20060014773A1
(en)
*
|
2001-04-19 |
2006-01-19 |
Mccleary Edward L |
Mental agility lozenge, edible strip, food or drink
|
|
JP2002348244A
(ja)
*
|
2001-05-23 |
2002-12-04 |
Fancl Corp |
抗糖尿病組成物
|
|
MXPA04006039A
(es)
*
|
2001-12-19 |
2004-09-27 |
The Quigley Corp |
Metodo para el tratamiento de afecciones vasculares y neuronales perifericas.
|
|
ITMI20012732A1
(it)
*
|
2001-12-20 |
2003-06-20 |
Health Pharma S R L |
Integratore alimentare per neuropatici
|
|
TW200304372A
(en)
*
|
2002-03-20 |
2003-10-01 |
Kanegafuchi Chemical Ind |
Compositions for diabetes
|
|
WO2003079819A1
(en)
*
|
2002-03-27 |
2003-10-02 |
Anglo French Drugs And Industries Ltd. |
Dietary supplement composition and a process of manufacturing said composition
|
|
US6974592B2
(en)
*
|
2002-04-11 |
2005-12-13 |
Ocean Nutrition Canada Limited |
Encapsulated agglomeration of microcapsules and method for the preparation thereof
|
|
US7977049B2
(en)
*
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
SE526943C2
(sv)
*
|
2002-08-26 |
2005-11-22 |
Indevex Ab |
Födoämneskompositionsprodukt
|
|
CA2471821C
(en)
*
|
2002-11-04 |
2006-04-25 |
Ocean Nutrition Canada Limited |
Microcapsules having multiple shells and method for the preparation thereof
|
|
US7083813B2
(en)
|
2002-11-06 |
2006-08-01 |
The Quigley Corporation |
Methods for the treatment of peripheral neural and vascular ailments
|
|
US7776913B2
(en)
|
2002-12-13 |
2010-08-17 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Carnitines for treating or preventing disorders caused by andropause
|
|
US20060025337A1
(en)
*
|
2003-07-01 |
2006-02-02 |
President And Fellows Of Harvard College |
Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
|
|
AU2004253579B2
(en)
|
2003-07-01 |
2010-12-23 |
Biomol International L.P. |
Sirt1 modulators for manipulating cells/organism lifespan/stress response
|
|
CA2436650A1
(en)
*
|
2003-08-06 |
2005-02-06 |
Naturia Inc. |
Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
|
|
US20050202063A1
(en)
*
|
2003-08-26 |
2005-09-15 |
Ebn International Kft |
Food product
|
|
US7875291B1
(en)
|
2003-09-05 |
2011-01-25 |
Glu-Pro, Inc. |
Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
|
|
EP1537896B1
(de)
*
|
2003-12-03 |
2008-04-02 |
Franz-Peter Dr. Liebel |
Stoffgemische basierend auf schwefelhaltigen Aminosäuren, Antioxidantien, Phospholipiden und Vitaminen zur Herstellung eines Arzneimittels für die Behandlung des L-Diabetes und/oder assoziierter Erkrankungen
|
|
US20050171027A1
(en)
*
|
2003-12-29 |
2005-08-04 |
President And Fellows Of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
|
CA2550625C
(en)
*
|
2003-12-31 |
2013-05-28 |
Integrative Health Consulting, Inc. |
Nutrient compositions and methods for enhanced effectiveness of the immune system
|
|
RU2350124C2
(ru)
*
|
2004-01-28 |
2009-03-27 |
Нестек С.А. |
Питательная композиция для улучшения состояния кожи и предотвращения кожных заболеваний
|
|
DK1577320T3
(da)
|
2004-03-19 |
2012-10-15 |
Pasteur Institut |
Peptider afledt fra humant BPLP-protein, polynukleotider kodende for nævnte peptider og antistoffer rettet mod nævnte peptider
|
|
US20050232911A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Schreiber Brian D |
Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
|
|
WO2006007411A2
(en)
*
|
2004-06-16 |
2006-01-19 |
President And Fellows Of Harvard College |
Methods and compositions for modulating bax-mediated apoptosis
|
|
EP1762234A4
(en)
*
|
2004-06-28 |
2010-05-05 |
Kao Corp |
AMPK AKTIVATOR
|
|
WO2006004722A2
(en)
*
|
2004-06-30 |
2006-01-12 |
Biomol Research Laboratories, Inc. |
Compositions and methods for selectively activating human sirtuins
|
|
ITRM20040395A1
(it)
*
|
2004-08-03 |
2004-11-03 |
Sigma Tau Ind Farmaceuti |
Composizione comprendente statine e acidi grassi omega 3.
|
|
US7709539B2
(en)
*
|
2004-08-11 |
2010-05-04 |
Chang Gung University |
Therapeutic use of resveratrol for hyperglycemia
|
|
AU2005322015B2
(en)
|
2004-12-29 |
2010-02-25 |
Hill's Pet Nutrition, Inc. |
Methods for inhibiting a decline in learning and/or memory in animals
|
|
US8034450B2
(en)
*
|
2005-01-21 |
2011-10-11 |
Ocean Nutrition Canada Limited |
Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
|
|
WO2006109194A2
(en)
*
|
2005-01-27 |
2006-10-19 |
Ocean Nutrition Canada Ltd. |
Chromium-fatty acid compounds and methods of making and using thereof
|
|
DE602006011127D1
(de)
*
|
2005-01-27 |
2010-01-28 |
Ocean Nutrition Canada Ltd |
Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
|
|
AU2006219823A1
(en)
*
|
2005-03-02 |
2006-09-08 |
Metanomics Gmbh |
Process for the production of fine chemicals
|
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
US9968120B2
(en)
*
|
2006-05-17 |
2018-05-15 |
Dsm Nutritional Products Ag |
Homogenized formulations containing microcapsules and methods of making and using thereof
|
|
RU2402919C2
(ru)
|
2005-07-14 |
2010-11-10 |
Хилл'С Пет Ньютришн, Инк. |
Способ продления жизни животных
|
|
WO2007016949A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risc of alcohol induced neuropathy
|
|
PL1909600T3
(pl)
|
2005-07-29 |
2012-09-28 |
Tima Found |
Kompozycja spowalniająca metabolizm alkoholu i ograniczająca ryzyko chorób wywołanych alkoholem
|
|
JP2007126390A
(ja)
*
|
2005-11-02 |
2007-05-24 |
Mercian Corp |
血糖値低下剤
|
|
GB0606864D0
(en)
*
|
2006-04-05 |
2006-05-17 |
Univ Nottingham |
Increades fatty acid oxidation
|
|
CA2643662A1
(en)
*
|
2006-04-07 |
2007-10-25 |
Ocean Nutrition Canada Ltd. |
Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
|
|
US20070281961A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Brite Age |
Modified Compositions And Methods For Enhancing Brain Function
|
|
US8883814B2
(en)
|
2006-06-05 |
2014-11-11 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function
|
|
US10105405B2
(en)
|
2006-06-05 |
2018-10-23 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
|
|
US10105406B2
(en)
|
2006-06-05 |
2018-10-23 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
|
|
US9308232B2
(en)
|
2006-06-05 |
2016-04-12 |
Keyview Labs, Inc. |
Compositions and methods for enhancing brain function
|
|
PL2040682T3
(pl)
*
|
2006-06-05 |
2018-01-31 |
Dsm Nutritional Products Ag |
Mikrokapsułki o ulepszonych otoczkach
|
|
US8071610B2
(en)
*
|
2006-06-05 |
2011-12-06 |
Josh Reynolds |
Compositions and methods for enhancing brain function
|
|
AU2008205325B2
(en)
|
2007-01-10 |
2013-09-12 |
Dsm Nutritional Products Ag |
Vegetarian microcapsules
|
|
US20080226696A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Ben Treadwell |
Methods of improving learning abilities of aged companion animals
|
|
ES2546619T3
(es)
*
|
2007-03-21 |
2015-09-25 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Composición útil para la prevención de la diabetes tipo 2 y sus complicaciones en pacientes pre-diabéticos con resistencia a la insulina
|
|
WO2008141897A1
(en)
*
|
2007-05-24 |
2008-11-27 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
|
|
US10519504B2
(en)
|
2009-05-11 |
2019-12-31 |
Berg Llc |
Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
|
|
US20120053437A1
(en)
*
|
2010-08-25 |
2012-03-01 |
Hickle Randall S |
Monitored healthcare process for the treatment of specific health problems with medical foods and/or drugs
|
|
EP2694463B8
(en)
|
2011-04-04 |
2019-10-09 |
Berg LLC |
Treating central nervous system tumors with coenzyme q10
|
|
US9040082B2
(en)
|
2011-06-24 |
2015-05-26 |
K-Pax Pharmaceuticals, Inc. |
Compositions and methods for treatment of chronic fatigue
|
|
EP3466418A1
(en)
|
2011-07-15 |
2019-04-10 |
NuSirt Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
CN108452311A
(zh)
|
2012-11-13 |
2018-08-28 |
纽斯尔特科学公司 |
用于增强能量代谢的组合物和方法
|
|
WO2014152016A1
(en)
|
2013-03-15 |
2014-09-25 |
Nusirt Sciences, Inc. |
Leucine and nicotinic acid reduces lipid levels
|
|
EA032775B1
(ru)
|
2013-04-08 |
2019-07-31 |
Берг Ллк |
Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
|
|
WO2015035094A1
(en)
|
2013-09-04 |
2015-03-12 |
Berg Llc |
Methods of treatment of cancer by continuous infusion of coenzyme q10
|
|
MX2016011063A
(es)
|
2014-02-27 |
2016-11-30 |
Nusirt Sciences Inc |
Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.
|
|
US10361003B2
(en)
|
2014-04-28 |
2019-07-23 |
Yeda Research And Development Co. Ltd. |
Method and apparatus for predicting response to food
|
|
WO2016174677A1
(en)
*
|
2015-04-28 |
2016-11-03 |
Yeda Research And Development Co. Ltd. |
Use of microbial metabolites for treating diseases
|
|
WO2017087576A1
(en)
|
2015-11-16 |
2017-05-26 |
Berg Llc |
Methods of treatment of temozolomide-resistant glioma using coenzyme q10
|
|
CN108378355A
(zh)
*
|
2018-01-06 |
2018-08-10 |
福建古瑞森生物科技有限公司 |
降低2型糖尿病患者餐后血糖改善血脂增加肠道有益菌的餐前预营养组合物及其制备方法
|